CClinicalTrials.gg
CompletedNCT04866173Updated Nov 10, 2021

Effects of Contact to Dogs During Stressful Situations

An interventional study of Dog and No Dog in Physiological Stress Responses to Standardises Stress Situations, Psychological Responses to Standardised Stress Situations and Behavioural Responses to Standardised Stress Situations, sponsored by University of Aarhus. Completed at 1 site in Denmark. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-11-10.

Sponsored by University of Aarhus · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The investigators will conduct an experimental study comparing responses of healthy participants in two test situations where they are subjected to mild stress. The study design is a randomised controlled crossover design nested within two groups - one with a dog present and another without a dog present. The participants will be randomly allocated to two groups (with dog and without dog) and the participants will receive both test situations on the same day. During the two test situations the participants will be subjected to a classical stress test , and exposed to tolerable pain, as well as periods with relaxation.

Read the detailed description

The study design is a randomised controlled crossover design, nested within two groups - one with a dog present (Dog) and another without a dog present (No Dog). Both groups will be subjected to a classical stress test - the Maastricht Acute Stress Test (MAST) and a pain test with periods of relaxation in between. The participants will be subjected to both test situations on the same day and in the same order.

On the test day, background information and baseline measures (baseline period, duration: 40 minutes) will be collected, whereafter the participants rest for 30 minutes (pre-intervention rest period). After this the participants are subjected to the two test situations, pain test (60 minutes, including calibration and two separate tests sessions) and MAST (15 minutes, including 5 min introduction) with 30 minutes of relaxation in between and a 40 min post-rest period The participants' interaction with the dog is recorded using quantitative behaviour sampling using predefined behavioural categories.

Most physiological and all behavioural measures are recorded continuously throughout test situations and relaxation, in order to be able to study the response to the stress situations and recovery, and the response to contact with dog, and to psychological responses. Some physiological measures obtained before and after each test situation.

Below the exact time schedule of the test day is shown and these times will be refered to when the outcome measures are described. The "Baseline period" (40 minutes) and the last 10 minutes where the equipment for physiological measures is removed is not included in the duration of the test period (174 minutes). All times are given in minutes.

Baseline period (40 minutes - not part of total test period)

  • Pre-intervention period (start t = 0; end t = 30)
  • Calibration for pain test (start t = 30, end t = 35)
  • Rest period 1 (start t = 35, end t = 47)
  • Pain test 1 (start t = 47, end t = 52)
  • Post-pain test 1 (start t = 52, end, t= 62)
  • Rest period 2 (start t = 62, end t = 74)
  • Pain test 2 (start t = 74, end t = 79)
  • Post-pain test 2 (start t = 79, end t = 89)
  • Rest period 3 (start t = 89, end t = 119)
  • MAST test (incl. introduction (start t = 119, end t = 134)
  • Rest period 4 (start t = 134, end t = 174)
02

Conditions studied

  • Physiological Stress Responses to Standardises Stress Situations
  • Psychological Responses to Standardised Stress Situations
  • Behavioural Responses to Standardised Stress Situations

Keywords

  • Human-animal contact
  • Non-invasive measure
  • Animal-assisted contact
03

In context

Lead sponsor

University of Aarhus is the lead sponsor of 1,274 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Normal cognitive functioning and physical movement
  • Ability to speak and read Danish

Exclusion criteria

Exclusion Criteria:

  • Known medical, psychiatric or neurological disease
  • Use of psychotropic medications
  • Frequent use of pain medication
  • Use of illegal psychotropic drugs
  • Known allergies to dogs
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Dog

    Being subjected to two standardised stress situations with a dog and its handler present

    Other: Dog

  • Experimental
    No Dog

    Being subjected to two standardised stress situations without a dog present, but in the presence of a person (dog handler)

    Other: No Dog

Interventions

  • OtherDog

    Subjection to standardised stress situations in the presence of a dog and a person

  • OtherNo Dog

    Subjection to standardised stress situations in the presence of a person

06

What researchers measure

Primary outcomes

  1. Physiological measure, heart rate

    The test person wears self-adhesive electrodes and the heart rate is measured non-invasively

    Time frame: Measured continuously throughout the total test period of 174 minutes (starting in the pre-intervention period and during the following test situations and all resting periods)]

  2. Physiological measure, systolic and diastolic blood pressure

    Blood pressure is measured manually with a blood pressure monitor with a blood pressure cuff.

    Time frame: Measured at the end of the 30 minute pre-intervention period (t=30 minutes)]

  3. Physiological measure, systolic and diastolic blood pressure

    Blood pressure is measured manually with a blood pressure monitor with a blood pressure cuff.

    Time frame: Measured at the end of Rest Period 1 (t=47 minutes)]

  4. Physiological measure, systolic and diastolic blood pressure

    Blood pressure is measured manually with a blood pressure monitor with a blood pressure cuff.

    Time frame: Measured after Pain test 1 (t=52 minutes)]

  5. Physiological measure, systolic and diastolic blood pressure

    Blood pressure is measured manually with a blood pressure monitor with a blood pressure cuff.

    Time frame: Measured at the end of Rest period 2 (t=74 minutes)]

  6. Physiological measure, systolic and diastolic blood pressure

    Blood pressure is measured manually with a blood pressure monitor with a blood pressure cuff.

    Time frame: Measured after Pain test 2 (t=79 minutes)]

  7. Physiological measure, systolic and diastolic blood pressure

    Blood pressure is measured manually with a blood pressure monitor with a blood pressure cuff.

    Time frame: Measured at the end of Rest period 3 (t=119 minutes)]

  8. Physiological measure, systolic and diastolic blood pressure

    Blood pressure is measured manually with a blood pressure monitor with a blood pressure cuff

    Time frame: Measured after MAST test (t=134 minutes)]

  9. Physiological measure, systolic and diastolic blood pressure

    Blood pressure is measured manually with a blood pressure monitor with a blood pressure cuff.

    Time frame: Measured after Rest period 4 (t=174 minutes)]

  10. Physiological measure, heart rate variability

    Heart rate variability is calculated from heart rate data.

    Time frame: Measured continuously throughout the total test period of 174 minutes (starting in the pre-intervention period and during the following test situations and all resting periods)]

  11. Galvanic skin response

    The test person is fitted with electrodes on two fingers and galvanic skin response is measured non-invasively.

    Time frame: Measured continuously throughout the total test period of 174 minutes (starting in the pre-intervention period and during the following test situations and all resting periods)]

  12. Salivary cortisol

    Saliva is obtained from the test subject with a cotton swab which is chewed for one minute.

    Time frame: Measured at the end of the 30 minute pre-intervention period (t=30 minutes)]

  13. Salivary cortisol

    Saliva is obtained from the test subject with a cotton swab which is chewed for one minute

    Time frame: Measured at the end of Rest Period 1 (t=47 minutes)]

  14. Salivary cortisol

    Saliva is obtained from the test subject with a cotton swab which is chewed for one minute

    Time frame: Measured after Post-pain test 1 (t=62 minutes)]

  15. Salivary cortisol

    Saliva is obtained from the test subject with a cotton swab which is chewed for one minute

    Time frame: Measured at the end of Rest period 2 (t=74 minutes)]

  16. Salivary cortisol

    Saliva is obtained from the test subject with a cotton swab which is chewed for one minute

    Time frame: Measured after Post-pain test 2 (t=89 minutes)]

  17. Salivary cortisol

    Saliva is obtained from the test subject with a cotton swab which is chewed for one minute

    Time frame: Measured at the end of Rest period 3 (t=119 minutes)]

  18. Salivary cortisol

    Saliva is obtained from the test subject with a cotton swab which is chewed for one minute

    Time frame: Measured after MAST test (t=134 minutes)]

  19. Salivary cortisol

    Saliva is obtained from the test subject with a cotton swab which is chewed for one minute

    Time frame: Measured 5 minutes after MAST test (t=139 minutes)]

  20. Salivary cortisol

    Saliva is obtained from the test subject with a cotton swab which is chewed for one minute

    Time frame: Measured 10 minutes after MAST test (t=144 minutes)]

  21. Salivary cortisol

    Saliva is obtained from the test subject with a cotton swab which is chewed for one minute

    Time frame: Measured 20 minutes after MAST test (t=154 minutes)]

  22. Salivary cortisol

    Saliva is obtained from the test subject with a cotton swab which is chewed for one minute

    Time frame: Measured 30 minutes after MAST test (t=164 minutes)]

  23. Salivary cortisol

    Saliva is obtained from the test subject with a cotton swab which is chewed for one minute

    Time frame: Measured 40 minutes after MAST test (t=174 minutes)]

  24. Visual analogue scales measuring expected psychological and physiological effects of the test day including, including the two test situation and the rest periods

    Test persons fill in a visual analogue scale. Minimum value -100 (very negative effect) and maximum value 100 (very positive effect), and 0 being neutral.

    Time frame: Baseline: Measured at onset of the 30 minute pre-intervention period (t=0 minutes)]

  25. Visual analogue scales measuring expected psychological and physiological effects of the two test situations

    Test persons fill in a visual analogue scale. Minimum value -100 (very negative effect) and maximum value 100 (very positive effect), and 0 being neutral.

    Time frame: : Measured immediately preceding Pain test 1 (t=47 minutes]

  26. Visual analogue scales measuring expected psychological and physiological effects of the two test situations

    Test persons fill in a visual analogue scale. Minimum value -100 (very negative effect) and maximum value 100 (very positive effect), and 0 being neutral.

    Time frame: : Measured immediately preceding Pain test 2 (t=74 minutes]

  27. Visual analogue scales measuring expected psychological and physiological effects of the two test situations

    Test persons fill in a visual analogue scale. Minimum value -100 (very negative effect) and maximum value 100 (very positive effect), and 0 being neutral.

    Time frame: : Measured immediately preceding MAST test (t=119 minutes]

  28. Visual analogue scales measuring perceived psychological and physiological effects of each of the two test situations

    Test persons fill in a visual analogue scale. Minimum value -100 (very negative effect) and maximum value 100 (very positive effect), and 0 being neutral.

    Time frame: Measured immediately following Pain test 1(t=52 minutes)

  29. Visual analogue scales measuring perceived psychological and physiological effects of each of the two test situations

    Test persons fill in a visual analogue scale. Minimum value -100 (very negative effect) and maximum value 100 (very positive effect), and 0 being neutral.

    Time frame: Measured immediately following Pain test 2 (t=79 minutes)

  30. Visual analogue scales measuring perceived psychological and physiological effects of each of the two test situations

    Test persons fill in a visual analogue scale. Minimum value -100 (very negative effect) and maximum value 100 (very positive effect), and 0 being neutral.

    Time frame: Measured immediately following MAST test 1 (t=134 minutes)

  31. Visual analogue scales measuring perceived psychological and physiological effects of of the test day including the test situations and rest period

    Test persons fill in a visual analogue scale. Minimum value -100 (very negative effect) and maximum value 100 (very positive effect), and 0 being neutral.

    Time frame: Measured immediately after Rest period 4 (t=174 minutes)

  32. The State-Trait Anxiety Inventory (STAI)

    State anxiety is measured with the STAI-scale (minimum score= 20, maximum score= 80, and a lower score indicates a high anxiety level)

    Time frame: Baseline: Measured at onset of the 30 minute pre-intervention period preceding the first test situation (t=0 minutes)]

  33. The State-Trait Anxiety Inventory (STAI)

    State anxiety is measured with the STAI-scale (minimum score= 20, maximum score= 80, and a lower score indicates a high anxiety level)

    Time frame: Measured immediately following Pain test 1 (t= 52 minutes)

  34. The State-Trait Anxiety Inventory (STAI)

    State anxiety is measured with the STAI-scale (minimum score= 20, maximum score= 80, and a lower score indicates a high anxiety level)

    Time frame: Measured immediately following Pain test 2 (t= 79 minutes)

  35. The State-Trait Anxiety Inventory (STAI)

    State anxiety is measured with the STAI-scale (minimum score= 20, maximum score= 80, and a lower score indicates a high anxiety level)

    Time frame: Measured immediately following MAST test 1 (t=134 minutes)

  36. The State-Trait Anxiety Inventory (STAI)

    State anxiety is measured with the STAI-scale (minimum score= 20, maximum score= 80, and a lower score indicates a high anxiety level)

    Time frame: Measured immediately after Rest period 4 (t=174 minutes)

  37. The Positive and Negative Affect Schedule (PANAS)

    Positive and negative affect is measured with the PANAS scale, where the person scores whether or not they experience each of 20 emotions on a 5-step scale from "very little /not at all" to "extremely much". The emotions differ in valens.

    Time frame: Baseline: Measured at onset of the 30 minute pre-intervention period preceding the first test situation (t=0 minutes)]

  38. The Positive and Negative Affect Schedule (PANAS)

    Positive and negative affect is measured with the PANAS scale, where the person scores whether or not they experience each of 20 emotions on a 5-step scale from "very little /not at all" to "extremely much". The emotions differ in valens.

    Time frame: Measured immediately following Pain test 1 (t= 52 minutes)

  39. The Positive and Negative Affect Schedule (PANAS)

    Positive and negative affect is measured with the PANAS scale, where the person scores whether or not they experience each of 20 emotions on a 5-step scale from "very little /not at all" to "extremely much". The emotions differ in valens.

    Time frame: Measured immediately following Pain test 2 (t= 79 minutes)

  40. The Positive and Negative Affect Schedule (PANAS)

    Positive and negative affect is measured with the PANAS scale, where the person scores whether or not they experience each of 20 emotions on a 5-step scale from "very little /not at all" to "extremely much". The emotions differ in valens.

    Time frame: Measured immediately following MAST test 1 (t=134 minutes)

  41. The Positive and Negative Affect Schedule (PANAS)

    Positive and negative affect is measured with the PANAS scale, where the person scores whether or not they experience each of 20 emotions on a 5-step scale from "very little /not at all" to "extremely much". The emotions differ in valens.

    Time frame: Measured immediately after Rest period 4 (t=174 minutes)

  42. Quantitative behavioural measures - frequencies of behavioural elements

    A video recording of the test persons behaviour is analysed for frequency of sitting.

    Time frame: Measured continuously throughout the total test period of 174 minutes (starting in the pre-intervention period and during the following test situations and all resting periods)]

  43. Quantitative behavioural measures - frequencies of behavioural elements

    A video recording of the test persons behaviour is analysed for frequency of standing.

    Time frame: Measured continuously throughout the total test period of 174 minutes (starting in the pre-intervention period and during the following test situations and all resting periods)]

  44. Quantitative behavioural measures - frequencies of behavioural elements

    A video recording of the test persons behaviour is analysed for frequency of walking.

    Time frame: Measured continuously throughout the total test period of 174 minutes (starting in the pre-intervention period and during the following test situations and all resting periods)]

  45. Quantitative behavioural measures - frequencies of behavioural elements

    A video recording of the test persons behaviour is analysed for frequency of touching the dog (being in physical contact with the dog with the hand or another part of the body, only in the arm: Dog)

    Time frame: Measured continuously throughout the total test period of 174 minutes (starting in the pre-intervention period and during the following test situations and all resting periods)]

  46. Quantitative behavioural measures - frequencies of behavioural elements

    A video recording of the test persons behaviour is analysed for frequency of looking at the dog (having the head turned towards the dog, only in the arm: Dog).

    Time frame: Measured continuously throughout the total test period of 174 minutes (starting in the pre-intervention period and during the following test situations and all resting periods)]

  47. Quantitative behavioural measures - frequencies of behavioural elements

    A video recording of the test persons behaviour is analysed for frequency of talking to the dog (Only in the arm: Dog).

    Time frame: Measured continuously throughout the total test period of 174 minutes (starting in the pre-intervention period and during the following test situations and all resting periods)]

  48. Quantitative behavioural measures - duration of behavioural elements

    A video recording of the test persons behaviour is analysed for the duration (seconds) of sitting.

    Time frame: Measured continuously throughout the total test period of 174 minutes (starting in the pre-intervention period and during the following test situations and all resting periods)]

  49. Quantitative behavioural measures - duration of behavioural elements

    A video recording of the test persons behaviour is analysed for the duration (seconds) of standing.

    Time frame: Measured continuously throughout the total test period of 174 minutes (starting in the pre-intervention period and during the following test situations and all resting periods)]

  50. Quantitative behavioural measures - duration of behavioural elements

    A video recording of the test persons behaviour is analysed for the duration (seconds) of walking.

    Time frame: Measured continuously throughout the total test period of 174 minutes (starting in the pre-intervention period and during the following test situations and all resting periods)]

  51. Quantitative behavioural measures - duration of behavioural elements

    A video recording of the test persons behaviour is analysed for the duration (seconds) of touching the dog (being in physical contact with the dog with the hand or another part of the body, only in the arm: Dog).

    Time frame: Measured continuously throughout the total test period of 174 minutes (starting in the pre-intervention period and during the following test situations and all resting periods)]

  52. Quantitative behavioural measures - duration of behavioural elements

    A video recording of the test persons behaviour is analysed for the duration (seconds) of looking at the dog (having the head turned towards the dog, only in the arm: Dog).

    Time frame: Measured continuously throughout the total test period of 174 minutes (starting in the pre-intervention period and during the following test situations and all resting periods)]

  53. Quantitative behavioural measures - duration of behavioural elements

    A video recording of the test persons behaviour is analysed for the duration (seconds) of talking to the dog (Only in the arm: Dog).

    Time frame: Measured continuously throughout the total test period of 174 minutes (starting in the pre-intervention period and during the following test situations and all resting periods)]

07

Study locations

1 site
  • Aarhus University
    Tjele, DK-8830, Denmark
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 10, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04866173
Lead sponsor
University of Aarhus
Responsible party
Sponsor
First posted
Apr 29, 2021
Start date
May 1, 2021
Primary completion
Oct 17, 2021
Completion
Oct 17, 2021
Last update
Nov 10, 2021

Study contacts

Karen Thodberg, PhD
principal investigator · University of Aarhus

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion